Hartford Financial Management Inc. Syndax Pharmaceuticals Inc Transaction History

Hartford Financial Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$4.9 - $9.31 $31,850 - $60,515	-6,500 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$4.26 - $6.86 $3,408 - $5,488	-800 Reduced 10.96%	6,500 $34,000
Q3 2018 Nov 01, 2018	BUY	$6.33 - $8.08 $39,879 - $50,904	6,300 Added 630.0%	7,300 $59,000
Q2 2018 Aug 10, 2018	BUY	$6.93 - $14.63 $6,930 - $14,630	1,000 New	1,000 $7,000

230

90M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $773M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hartford Financial Management Inc. with notifications on news.